D-1403-2012 Class III Terminated

Recalled by Watson Laboratories Inc — Corona, CA

FDA drug recall D-1403-2012 was initiated by Watson Laboratories Inc on Apr 17, 2012 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged. The recall status is terminated (terminated Mar 18, 2013). Affected quantity: 7,262 bottles.

Recall details

Product Type
Drugs
Report Date
Jul 11, 2012
Initiation Date
Apr 17, 2012
Termination Date
Mar 18, 2013
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
7,262 bottles

Product description

Loxitane Capsules, Loxapine Succinate Capsules, 10mg base, 100 count bottle, Rx only, Watson Laboratories Inc., Corona, CA 92880 NDC # 52544-495-01

Reason for recall

Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.

Distribution pattern

Nationwide.

Code information

Lot # 22478A

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1403-2012
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1403-2012. Report a data issue: hello@regdatalab.com.